{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:54:50Z","timestamp":1790463290363,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/pas.0000000000000434","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T17:22:21Z","timestamp":1428081741000},"page":"1132-1139","source":"Crossref","is-referenced-by-count":66,"title":["Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations\/Rearrangements"],"prefix":"10.1097","volume":"39","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210131","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells.","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev"},{"key":"R2-14-20210131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1097-0142(19930701)72:1<231::AID-CNCR2820720141>3.0.CO;2-5","article-title":". bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features.","volume":"72","author":"Jacobson","year":"1993","journal-title":"Cancer"},{"key":"R3-14-20210131","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/asheducation-2013.1.575","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.","volume":"2013","author":"Ott","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R4-14-20210131","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":". Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL).","volume":"22","author":"Klapper","year":"2008","journal-title":"Leukemia"},{"key":"R5-14-20210131","doi-asserted-by":"crossref","first-page":"e95020","DOI":"10.1371\/journal.pone.0095020","article-title":". C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiologic studies.","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"R6-14-20210131","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":". Double-hit B-cell lymphomas.","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"R7-14-20210131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":". B-cell lymphomas with MYC8q24 rearrangements and IGHBCL2t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"R8-14-20210131","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":". Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"R9-14-20210131","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/cncr.28899","article-title":"MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.","volume":"120","author":"Petrich","year":"2014","journal-title":"Cancer"},{"key":"R10-14-20210131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAP.0b013e3182a289f2","article-title":". MYCBCL2 double-hit high-grade B-cell lymphoma.","volume":"20","author":"Li","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R11-14-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":". Lymphoid neoplasms associated with concurrent t(14;18) and 8q24c-MYC translocation generally have a poor prognosis.","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"key":"R12-14-20210131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":". Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R13-14-20210131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3324\/haematol.2013.091827","article-title":". Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.","volume":"99","author":"Aukema","year":"2014","journal-title":"Haematologica"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":". Clinicopathological features of lymphomaleukemia patients carrying both BCL2 and MYC translocations.","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"R15-14-20210131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cancergencyto.2010.08.018","article-title":". Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.","volume":"203","author":"Motllo","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"R16-14-20210131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/gcc.20831","article-title":". Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.","volume":"50","author":"Bacher","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R17-14-20210131","first-page":"788","article-title":". Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.","volume":"6","author":"Xu","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R18-14-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":". The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24c-MYC rearrangement.","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"R19-14-20210131","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/sj.leu.2401910","article-title":". De novo acute B cell leukemialymphoma with t(14;18).","volume":"14","author":"Stamatoullas","year":"2000","journal-title":"Leukemia"},{"key":"R20-14-20210131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cancergencyto.2006.07.005","article-title":"Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature.","volume":"171","author":"DAchille","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"R21-14-20210131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2141.1999.01347.x","article-title":". Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas.","volume":"105","author":"Au","year":"1999","journal-title":"Br J Haematol"},{"key":"R22-14-20210131","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12185-013-1414-9","article-title":". Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.","volume":"98","author":"So","year":"2013","journal-title":"Int J Hematol"},{"key":"R23-14-20210131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DAD.0b013e31829beaa7","article-title":". Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination.","volume":"36","author":"Magro","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R24-14-20210131","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood-2012-10-451716","article-title":"Double hit, triple hitlook for it.","volume":"121","author":"Benz","year":"2013","journal-title":"Blood"},{"key":"R25-14-20210131","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1182\/blood-2013-11-540658","article-title":"A leukemic presentation of a triple-hit lymphoma.","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"R26-14-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/08998280.2014.11929083","article-title":". Triple-hit lymphoma.","volume":"27","author":"Pemmaraju","year":"2014","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R27-14-20210131","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/PAT.0b013e3283634dec","article-title":". Multiple cytokine- and multiple cytokine receptor-expressing triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitts lymphoma.","volume":"45","author":"Nakayama","year":"2013","journal-title":"Pathology"},{"key":"R28-14-20210131","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.5858\/arpa.2013-0537-OA","article-title":". Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.","volume":"138","author":"Jabbar","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R29-14-20210131","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":". Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"R30-14-20210131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":". Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R31-14-20210131","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":". Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.","volume":"208","author":"Muris","year":"2006","journal-title":"J Pathol"},{"key":"R32-14-20210131","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","article-title":". Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"key":"R33-14-20210131","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/modpathol.2009.73","article-title":". Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.","volume":"22","author":"Nyman","year":"2009","journal-title":"Mod Pathol"},{"key":"R34-14-20210131","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1358","article-title":". Foxp1 is an essential transcriptional regulator of B cell development.","volume":"7","author":"Hu","year":"2006","journal-title":"Nature Immunol"},{"key":"R35-14-20210131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2559.2010.03600.x","article-title":". FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.","volume":"57","author":"Hoeller","year":"2010","journal-title":"Histopathology"},{"key":"R36-14-20210131","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","article-title":". Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.","volume":"104","author":"Barrans","year":"2004","journal-title":"Blood"},{"key":"R37-14-20210131","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.1065.11.3","article-title":". Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.","volume":"11","author":"Banham","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R38-14-20210131","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","article-title":". Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.","volume":"24","author":"Sagaert","year":"2006","journal-title":"J Clin Oncol"},{"key":"R39-14-20210131","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1182\/blood-2010-10-312231","article-title":". Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.","volume":"117","author":"Craig","year":"2011","journal-title":"Blood"},{"key":"R40-14-20210131","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2014-01-553412","article-title":". FOXP1 directly represses transcription of pro-apoptotic genes and cooperates with NF-kappaB to promote survival of human B-cells.","volume":"124","author":"van Keimpema","year":"2014","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T05:22:22Z","timestamp":1691558542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201508000-00014"}},"subtitle":["Clinicopathologic Features of 11 Cases"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000434","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}